Literature DB >> 20012493

Effects of blockade of dopamine D2 receptors on extracellular citrulline levels in the nucleus accumbens during performance of a conditioned reflex fear response.

N B Saul'skaya1, N V Fofonova, P V Sudorgina.   

Abstract

Vital microdialysis studies on Sprague-Dawley rats using HPLC showed that performance of a conditioned reflex fear response was accompanied by an increase in the extracellular level of citrulline (a coproduct of nitric oxide synthesis) in the nucleus accumbens. Administration of the dopamine D(2) receptor antagonist raclopride (10 microM) into the nucleus accumbens decreased the magnitude of the increase in the extracellular citrulline level in this structure during performance of the conditioned reflex fear response but had no effect on its behavioral measures (the level of freezing). Doses increased investigative activity in a novel context which had been inhibited by acquisition of the conditioned reflex fear response, without affecting the investigative behavior of control animals. These data suggest that the dopaminergic input and dopamine D(2) receptors control the activity of the NO-ergic system of the nucleus accumbens during performance of the conditioned reflex fear response and may control "transfer" of fear to another behavioral situation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012493     DOI: 10.1007/s11055-009-9225-4

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  27 in total

1.  [Th effect of D2-dopamine receptor blockade on glutamate release into extracellular space of Nucleus accumbens during food reinforcement].

Authors:  N B Saul'skaia; M O Mikhaĭlova
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  2001 Mar-Apr       Impact factor: 0.437

2.  [Influence of local administration of apomorphine on citrulline extracellular level in the striatum: participation of the dopamine D1 and D2 receptors].

Authors:  S A Savel'ev
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2005-08

3.  Interesting times for dopamine receptors.

Authors:  P G Strange
Journal:  Trends Neurosci       Date:  1991-02       Impact factor: 13.837

Review 4.  Pavlovian conditioning and its proper control procedures.

Authors:  R A Rescorla
Journal:  Psychol Rev       Date:  1967-01       Impact factor: 8.934

5.  [NO-synthase dependent increase in citrulline extracellular level in the nucleus accumbens during acquisition and expression of conditioned emotional response].

Authors:  N B Saul'skaia; S A Savel'ev; N A Solov'eva; N V Fofonova
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2006-06

6.  Neurons in medial prefrontal cortex signal memory for fear extinction.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Nature       Date:  2002-11-07       Impact factor: 49.962

7.  Localization of nitric oxide synthase indicating a neural role for nitric oxide.

Authors:  D S Bredt; P M Hwang; S H Snyder
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

Review 8.  Prefrontal involvement in the regulation of emotion: convergence of rat and human studies.

Authors:  Gregory J Quirk; Jennifer S Beer
Journal:  Curr Opin Neurobiol       Date:  2006-11-03       Impact factor: 6.627

9.  7-nitroindazole, nNOS inhibitor, attenuates amphetamine-induced amino acid release and nitric oxide generation but not lipid peroxidation in the rat brain.

Authors:  V Bashkatova; M M Kraus; A Vanin; A Hornick; A Philippu; H Prast
Journal:  J Neural Transm (Vienna)       Date:  2004-10-27       Impact factor: 3.575

10.  Carbachol injections into the nucleus accumbens disrupt acquisition and expression of fear-potentiated startle and freezing in rats.

Authors:  I Schwienbacher; H-U Schnitzler; R F Westbrook; R Richardson; M Fendt
Journal:  Neuroscience       Date:  2006-04-03       Impact factor: 3.590

View more
  1 in total

Review 1.  Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.

Authors:  Willem Johan van den Brink; Semra Palic; Isabelle Köhler; Elizabeth Cunera Maria de Lange
Journal:  Pharm Res       Date:  2018-02-15       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.